Heidelberg Pharma AG (LTS:0QW5) Accounts Payable & Accrued Expense : €4.12 Mil (As of Feb. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Heidelberg Pharma AG Accounts Payable & Accrued Expense?

Heidelberg Pharma AG's quarterly accounts payable & accrued expense increased from Aug. 2024 (€5.22 Mil) to Nov. 2024 (€5.78 Mil) but then declined from Nov. 2024 (€5.78 Mil) to Feb. 2025 (€4.12 Mil).

Heidelberg Pharma AG's annual accounts payable & accrued expense increased from Nov. 2022 (€6.05 Mil) to Nov. 2023 (€8.10 Mil) but then declined from Nov. 2023 (€8.10 Mil) to Nov. 2024 (€5.78 Mil).

Heidelberg Pharma AG Accounts Payable & Accrued Expense Historical Data

The historical data trend for Heidelberg Pharma AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG Accounts Payable & Accrued Expense Chart

Heidelberg Pharma AG Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.04

1.17

6.05

8.10

5.78

Heidelberg Pharma AG Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5.07	4.80	5.22	5.78	4.12

Heidelberg Pharma AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Heidelberg Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (LTS:0QW5) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

HPHA:Germany

Address

Gregor-Mendel-Street 22, Ladenburg, DEU, 68526

Website

https://www.heidelberg-pharma.com

Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.

Heidelberg Pharma AG Headlines

No Headlines